Vision: The United States will work domestically and internationally to prevent, detect, and control illness and death related to infections caused by antibiotic- resistant bacteria by implementing measures to mitigate the emergence and spread of antibiotic resistance and ensuring the continued availability of therapeutics for the treatment of bacterial infections.

Read the full report >>

• Terminal disinfection with ultraviolet device in Clostridium difficile rooms.
• Compliance improved from 20% to 100% during a 25 month study.
• Audit and feedback utilized to drive compliance of ultraviolet disinfection.

Touchless ultraviolet disinfection (UVD) devices effectively reduce the bioburden of epidemiologically relevant pathogens, including Clostridium difficile. During a 25-month implementation period, UVD devices were deployed facilitywide for the terminal disinfection of rooms that housed a patient who tested positive for C difficile. The deployment was performed with structured education, audit and feedback, and resulted in a multidisciplinary practice change that maximized the UVD capture rate from 20% to 100%.

More information: Deployment of a touchless ultraviolet light robot for terminal room disinfection: The importance of audit and feedback